Skip to main content
Equibles

FEDERATED HERMES, INC.

Position in FLNA — Filana Therapeutics, Inc.

CIK 1056288 PITTSBURGH, PA
Back to FLNA Full portfolio

Position in FLNA

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$142,742
-$51,771 QoQ
Shares Held
119,952
+4.2% QoQ
Ownership
0.248%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 84 holders
Holding Since
Mar 2021
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FLNA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FEDERATED HERMES, INC. holds $2,485,861,142 across 149 Biotechnology names. FLNA ranks #103 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
 719,905 $216,713,000
2 RYTM
Rhythm Pharmaceuticals, Inc.
 1,785,716 $198,268,046
3 REGN
Regeneron Pharmaceuticals, Inc.
 256,884 $160,177,448
4 MRNA
Moderna, Inc.
 1,794,778 $125,688,301
5 KYMR
Kymera Therapeutics, Inc.
 749,398 $85,933,468
6 EYPT
EyePoint, Inc.
 5,681,052 $81,239,042
7 ARGX
Argenx SE
 87,288 $80,983,187
8 ZBIO
Zenas BioPharma, Inc.
 3,116,805 $79,104,510

All Filings in FLNA

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $142,742 119,952
2026-03-31 $194,513 115,097
2025-12-31 $181,128 91,479
2025-09-30 $125,959 43,285
2025-06-30 $67,712 37,410
2025-03-31 $56,115 37,410
2024-12-31 $16,756 7,100
2022-09-30 $173,971 4,160
2022-06-30 $42,939 1,527
2021-06-30 $6,408 75
2021-03-31 $5,978 133